# | Title | Journal | Year | Citations |
---|
1 | Intestinal microbiota is altered in patients with colon cancer and modified by probiotic intervention | BMJ Open Gastroenterology | 2017 | 266 |
2 | Alteration in the gastric microbiota and its restoration by probiotics in patients with functional dyspepsia | BMJ Open Gastroenterology | 2017 | 98 |
3 | Cachexia in cancer: what is in the definition? | BMJ Open Gastroenterology | 2016 | 97 |
4 | Efficacy of dietary and physical activity intervention in non-alcoholic fatty liver disease: a systematic review | BMJ Open Gastroenterology | 2017 | 95 |
5 | Mechanisms of liver disease in patients infected with HIV | BMJ Open Gastroenterology | 2017 | 91 |
6 | Statins, antidiabetic medications and liver histology in patients with diabetes with non-alcoholic fatty liver disease | BMJ Open Gastroenterology | 2016 | 90 |
7 | High potency multistrain probiotic improves liver histology in non-alcoholic fatty liver disease (NAFLD): a randomised, double-blind, proof of concept study | BMJ Open Gastroenterology | 2019 | 82 |
8 | Systemic sclerosis is associated with specific alterations in gastrointestinal microbiota in two independent cohorts | BMJ Open Gastroenterology | 2017 | 77 |
9 | Novelty in the gut: a systematic review and meta-analysis of the gastrointestinal manifestations of COVID-19 | BMJ Open Gastroenterology | 2020 | 72 |
10 | Impact of introducing a faecal immunochemical test (FIT) for haemoglobin into primary care on the outcome of patients with new bowel symptoms: a prospective cohort study | BMJ Open Gastroenterology | 2019 | 68 |
11 | Gut microbiota associated with HIV infection is significantly enriched in bacteria tolerant to oxygen | BMJ Open Gastroenterology | 2016 | 66 |
12 | Consensus for the management of pancreatic exocrine insufficiency: UK practical guidelines | BMJ Open Gastroenterology | 2021 | 62 |
13 | Iron deficiency anaemia: pathophysiology, assessment, practical management | BMJ Open Gastroenterology | 2022 | 59 |
14 | Assessment of health utilities and quality of life in patients with non-alcoholic fatty liver disease | BMJ Open Gastroenterology | 2016 | 58 |
15 | Gastric microbiota in the functional dyspepsia patients treated with probiotic yogurt | BMJ Open Gastroenterology | 2016 | 57 |
16 | Hepatic macrophages in liver fibrosis: pathogenesis and potential therapeutic targets | BMJ Open Gastroenterology | 2016 | 53 |
17 | Faecal microbiota transplantation: applications and limitations in treating gastrointestinal disorders | BMJ Open Gastroenterology | 2016 | 53 |
18 | Gastroenterological and hepatic manifestations of patients with COVID-19, prevalence, mortality by country, and intensive care admission rate: systematic review and meta-analysis | BMJ Open Gastroenterology | 2021 | 53 |
19 | How bad is bile acid diarrhoea: an online survey of patient-reported symptoms and outcomes | BMJ Open Gastroenterology | 2017 | 52 |
20 | Growth patterns of colorectal cancer liver metastases and their impact on prognosis: a systematic review | BMJ Open Gastroenterology | 2018 | 52 |
21 | Changes in the gut microbiota composition and the plasma ghrelin level in patients withHelicobacter pylori-infected patients with eradication therapy | BMJ Open Gastroenterology | 2017 | 49 |
22 | Gastrointestinal mucosal damage in patients with COVID-19 undergoing endoscopy: an international multicentre study | BMJ Open Gastroenterology | 2021 | 49 |
23 | Effectiveness of screening for colorectal cancer with a faecal occult-blood test, in Finland | BMJ Open Gastroenterology | 2015 | 48 |
24 | Reliability and validity of the Chronic Liver Disease Questionnaire (CLDQ) in adults with non-alcoholic steatohepatitis (NASH) | BMJ Open Gastroenterology | 2016 | 47 |
25 | Weight regain after Roux-en-Y gastric bypass has a large negative impact on the Bariatric Quality of Life Index | BMJ Open Gastroenterology | 2017 | 47 |
26 | Combination therapy with vedolizumab and etanercept in a patient with pouchitis and spondylarthritis | BMJ Open Gastroenterology | 2017 | 47 |
27 | Alcohol and hepatocellular carcinoma | BMJ Open Gastroenterology | 2019 | 46 |
28 | Pitfalls in diagnosis and treatment of alveolar echinococcosis: a sentinel case series | BMJ Open Gastroenterology | 2015 | 44 |
29 | Risk factors for colorectal cancer significantly vary by anatomic site | BMJ Open Gastroenterology | 2019 | 44 |
30 | Circulating miRNA in patients with non-alcoholic fatty liver disease and coronary artery disease | BMJ Open Gastroenterology | 2016 | 43 |
31 | Gallstone ileus: a review | BMJ Open Gastroenterology | 2019 | 42 |
32 | Panenteric capsule endoscopy versus ileocolonoscopy plus magnetic resonance enterography in Crohn’s disease: a multicentre, prospective study | BMJ Open Gastroenterology | 2020 | 42 |
33 | Risk of common infections in people with inflammatory bowel disease in primary care: a population-based cohort study | BMJ Open Gastroenterology | 2021 | 42 |
34 | Cost-effectiveness of adalimumab, infliximab or vedolizumab as first-line biological therapy in moderate-to-severe ulcerative colitis | BMJ Open Gastroenterology | 2016 | 41 |
35 | Duodenal biopsies for the diagnosis of coeliac disease: are we adhering to current guidance? | BMJ Open Gastroenterology | 2017 | 39 |
36 | Gastrointestinal lymphoma: the new mimic | BMJ Open Gastroenterology | 2019 | 39 |
37 | Lost microbes of COVID-19: Bifidobacterium, Faecalibacterium depletion and decreased microbiome diversity associated with SARS-CoV-2 infection severity | BMJ Open Gastroenterology | 2022 | 39 |
38 | The societal burden of chronic liver diseases: results from the COME study | BMJ Open Gastroenterology | 2015 | 38 |
39 | Case report and literature review of auto-brewery syndrome: probably an underdiagnosed medical condition | BMJ Open Gastroenterology | 2019 | 38 |
40 | Traditional serrated adenoma: an overview of pathology and emphasis on molecular pathogenesis | BMJ Open Gastroenterology | 2019 | 38 |
41 | A randomised, placebo-controlled study of RIPK1 inhibitor GSK2982772 in patients with active ulcerative colitis | BMJ Open Gastroenterology | 2021 | 37 |
42 | Sex differences in disease presentation, treatment and clinical outcomes of patients with hepatocellular carcinoma: a single-centre cohort study | BMJ Open Gastroenterology | 2016 | 35 |
43 | Endoscopic ultrasound (EUS) and the management of pancreatic cancer | BMJ Open Gastroenterology | 2020 | 35 |
44 | Tacrolimus or infliximab for severe ulcerative colitis: short-term and long-term data from a retrospective observational study | BMJ Open Gastroenterology | 2015 | 34 |
45 | Vitamin D associates with improved quality of life in participants with irritable bowel syndrome: outcomes from a pilot trial | BMJ Open Gastroenterology | 2015 | 34 |
46 | Safety of dual biological therapy in Crohn’s disease: a case series of vedolizumab in combination with other biologics | BMJ Open Gastroenterology | 2018 | 34 |
47 | Pneumatosis intestinalis in COVID-19 | BMJ Open Gastroenterology | 2020 | 34 |
48 | Gut microbiome identifies risk for colorectal polyps | BMJ Open Gastroenterology | 2019 | 33 |
49 | Depression, anxiety and stress among patients with inflammatory bowel disease during the COVID-19 pandemic: Australian national survey | BMJ Open Gastroenterology | 2021 | 33 |
50 | Life in lockdown: experiences of patients with IBD during COVID-19 | BMJ Open Gastroenterology | 2020 | 32 |